CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Episodes 16-30 of 821
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
CME/CETime Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
MinuteCE®Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
Moving Forward–What Is on the Horizon? Personalized Therapies for Patients
MinuteCE®Moving Forward–What Is on the Horizon? Personalized Therapies for Patients
Evaluating Emerging Treatment Options: Rebalancing Therapies
MinuteCE®Evaluating Emerging Treatment Options: Rebalancing Therapies
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
CME/CETreatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
MinuteCE®Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
- advertisement
An Overview of Current and Emerging Treatment Options for Hemophilia A & B
MinuteCE®An Overview of Current and Emerging Treatment Options for Hemophilia A & B
Multidisciplinary Team Collaboration in the New Era of Hemophilia Treatment
MinuteCE®Multidisciplinary Team Collaboration in the New Era of Hemophilia Treatment
Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
MinuteCE®Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
The Impact of Hemophilia Across Patients’ Lives
MinuteCE®The Impact of Hemophilia Across Patients’ Lives
- advertisement
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
CME/CEEnhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
Chairperson Perspective: Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates
CME/CEChairperson Perspective: Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates
